arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Neuraxis, INC

NRXS

$6.04 ▼ -0.79 (-11.57%) at close

5 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Neuraxis, INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $54.9M

Dividend Yield —

Revenue Growth 32.9% ↗

Op. Margin -219.4% ↗

ROIC -182.0% ↗

FCF / Share $-0.71 ↗

Trailing P/E —

Price / Book 18.9x

FCF Yield —

Debt / Equity 0.04

info Valuation on last close. End-of-day price, Nov 5, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.57M

↑ +32.9% —

Net Income Profit after all expenses

$-7.80M

↑ +5.4% —

Operating Margin Operating profit as % of sales

-219.4%

↑ +17.7% 0th

FCF / Share Free cash flow per share

$-0.71

↑ +19.6% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue Growth YoY (%)	32.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+311%)	9.2% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15%)	-8.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-205%)	—	—
EPS Growth YoY (%)	22.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	72.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-62.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	5.4% Fair ↑ Fair Improving Year-over-year change in net income	43.7% Excellent Excellent Year-over-year change in net income	-206.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	19.6% Good ↑ Good Improving Year-over-year change in free cash flow	57.2% Excellent Excellent Year-over-year change in free cash flow	-80.1% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	10.0% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Operating Margin (%) (%)	-219.4% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1562%)	-266.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1876%)	-270.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1906%)	-125.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-937%)	—
Profit Margin (%) (%)	-218.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1921%)	-306.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2657%)	—	-178.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1584%)	—
FCF Margin (%) (%)	-181.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-228.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-273.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-85.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	-182.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-273.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	375.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	49.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-122.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-150.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1308.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-227.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-229.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1630%)	—	—	85.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+472%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Debt to Equity (x)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	—	-0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-107%)	—
Interest Coverage (x)	-105.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-41.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-4.82M	$-3.54M	$-78.56K	$-25.36K	—
Debt / EBITDA (x)	-0.02x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue per Share (USD)	$0.39	$0.39	$0.76	$1.34	—
Basic EPS, GAAP (USD)	$-0.95	$-1.22	$-4.50	$-2.77	—
Free Cash Flow per Share (USD)	$-0.71	$-0.89	$-2.07	$-1.15	—
Book Value per Share (USD)	$0.32	$0.30	$-0.22	$-2.84	—
Tangible Book Value per Share (USD)	$0.32	$0.30	$-0.22	$-2.84	—
Basic Weighted Avg Shares (shares)	9.08M	6.92M	3.25M	2.00M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$2.94M	$1.83M	$-1.64M	$-6.50M	—
LT Debt (USD)	—	—	—	$228.34K	—
Total Equity (USD)	$3.40M	$2.07M	$-1.40M	$-5.57M	$-825.66K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$3.57M	$2.69M	$2.46M	$2.68M	—
Depreciation Expense (USD)	$37.69K	$37.83K	$40.73K	$37.13K	—
Net Income, GAAP (USD)	$-7.80M	$-8.24M	$-14.63M	$-4.78M	—
Operating Cash Flow (USD)	$-6.43M	$-6.10M	$-6.69M	$-2.30M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 19 quarters

Neuraxis, INC

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NRXS with peers